7,001
+0.14%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Kobayashi Pharmaceutical Co
Its shares trade on Tokyo Stock Exchange under the ticker 4967.T. It has been listed since 20 April 1999. In the fiscal year to 31 December 2025, it reported revenue of ¥165.74bn and net income of ¥3.66bn. At that date it held total assets of ¥275.33bn and shareholders' equity of ¥211.00bn.
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. The company is headquartered in Osaka, Osaka-Fu. The firm operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Products
- Listed since
- 20 Apr 1999
- Employees
- 3,435
- Website
- kobayashi.co.jp ↗
Leadership
Pay as last reported
- Mr. Yoshihito OtaNon-Executive Chairman of the Board, Director
- Mr. Gaichi ToyotaPresident, Representative Director, since 2025
- Mr. Noriaki HiraoDirector of Finance & Accounting
- Mr. Fujito OhwakiManaging Executive Officer, Director of Business in Healthcare Business Unit
- Mr. Kenji KoboriExecutive Officer, Chief Director of Sales
- Mr. Jun SatoExecutive Officer, Deputy Chief Director of Main Sales Unit
- Mr. Ryo IshidoExecutive Officer, Manager of CDO Unit
- Mr. Takuya MatsushitaExecutive Officer, Director of China Strategy in International Business Unit
- Ms. Yumi NakagawaExecutive Officer, Manager of CFO Unit
- Mr. Atsushi OnoyamaExecutive Officer, Director of Business Unit in Daily Necessities Business Unit
- Mr. Norikazu ToyodaExecutive Officer, Director of Business in International Business Unit
- Mr. Atsushi WatanabeExecutive Officer, Chief Director of Main Reliability Assurance Unit
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 66
- Environment
- 57
- Social
- 61
- Governance
- 78
- Direct emissions (scope 1)
- 6,000 t
- Energy emissions (scope 2)
- 23,000 t
- Value chain emissions (scope 3)
- 559,000 t
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Kobayashi Pharmaceutical Co Ltd possesses several strengths that contribute to its competitive advantage in the market. Firstly, the company has a long-standing history and experience, which provides it with a strong foundation and reputation. This enhances customer trust and loyalty towards its products.
- Additionally, Kobayashi Pharmaceutical Co Ltd has a diverse product portfolio that caters to a wide range of consumer needs. This helps the company to mitigate risks associated with dependence on a single product line and allows for revenue diversification.
- Furthermore, the company boasts a strong research and development team that consistently delivers innovative products. This enables Kobayashi Pharmaceutical Co Ltd to stay ahead of competitors and adapt to changing market trends effectively.
Weaknesses
- Despite its strengths, Kobayashi Pharmaceutical Co Ltd also faces certain weaknesses that can hinder its growth. One such weakness is its limited global market presence. The company primarily operates within the domestic market, limiting its potential for international expansion and reducing exposure to diverse customer bases.
- Additionally, Kobayashi Pharmaceutical Co Ltd may face challenges in optimizing its supply chain and distribution network. These challenges can impact operational efficiency and lead to delays in reaching customers, potentially resulting in reduced customer satisfaction.
Opportunities
- There are several opportunities for Kobayashi Pharmaceutical Co Ltd to capitalize on. Firstly, there is a growing global demand for health and wellness products, which aligns with the company's core offerings. By expanding its presence in international markets, Kobayashi Pharmaceutical Co Ltd can tap into this demand and drive revenue growth.
- Furthermore, the company can explore strategic partnerships and collaborations with other healthcare organizations to enhance its product offerings or gain access to new markets. This can facilitate knowledge exchange and enable Kobayashi Pharmaceutical Co Ltd to leverage synergies in research and marketing efforts.
Threats
- Despite the potential opportunities, Kobayashi Pharmaceutical Co Ltd must also be aware of potential threats. One major threat is intense competition within the pharmaceutical industry. The company operates in a highly competitive market where other players constantly introduce new products and innovations. This may impact market share and profitability.
- Additionally, changing government regulations and policies can pose challenges to the company's operations. Compliance with evolving regulatory requirements may require substantial resources and could disrupt business processes if not managed effectively.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.